Idiopathic Pulmonary Fibrosis (IPF) Market Size, Epidemiology, In-Market Drugs Sales, Pipeline Therapies, and Regional Outlook 2025-2035

Report Format: PDF+Excel | Report ID: SR112025A6457

Market Overview:

The idiopathic pulmonary fibrosis (IPF) market reached a value of USD 3,805.2 Million across the top 7 markets (US, EU4, UK, and Japan) in 2024. Looking forward, IMARC Group expects the top 7 major markets to reach USD 7,451.4 Million by 2035, exhibiting a growth rate (CAGR) of 6.32% during 2025-2035.

Report Attribute	Key Statistics
Base Year	2024
Forecast Years	2025-2035
Historical Years	2019-2024
Market Size in 2024	USD 3,805.2 Million
Market Forecast in 2035	USD 7,451.4 Million
Market Growth Rate (2025-2035)	6.32%

The idiopathic pulmonary fibrosis (IPF) market has been comprehensively analyzed in IMARC's new report titled "Idiopathic Pulmonary Fibrosis (IPF) Market Size, Epidemiology, In-Market Drugs Sales, Pipeline Therapies, and Regional Outlook 2025-2035". Idiopathic Pulmonary Fibrosis (IPF) market is currently driven by factors such as a rising geriatric population, cigarette smoking, a strong drug pipeline that have a good efficacy and safety profile and improving diagnosis and drug treatment rates. Idiopathic Pulmonary Fibrosis represents the most common of the idiopathic interstitial pneumonias and is characterized by a chronic, progressive, fibrotic interstitial lung disease having an unknown cause. This disease rarely occurs before the age of 50 years and primarily affects older adults (60+). With the geriatric population expected to increase considerably over the long term, we expect the incidence of Idiopathic Pulmonary Fibrosis to increase significantly over the next few years.

In patients with IPF, the tiny air sacs in the lungs (alveoli) get damaged and increasingly scarred. This results in the lungs becoming stiff, which makes it hard for oxygen to get into the blood. The causes of IPF are unknown, but various risk factors have been identified, including older age, cigarette smoking, environmental exposures, certain infections, etc. Cigarette smoking, particularly involving more than 20 pack-years, represents the most strongly associated ecological risk factor. Furthermore, heightened risk for IPF has been associated with various environmental exposures (metal dusts, automobile emissions, and wood dust). Occupations such as agriculture and managing livestock have also been associated with IPF. There is a high unmet need for novel therapies to treat IPF, as conventional drugs have limited efficacy or an unfavorable safety profile.

IMARC Group's new report provides an exhaustive analysis of the Idiopathic Pulmonary Fibrosis market in the United States, EU4 (Germany, Spain, Italy, and France), United Kingdom, and Japan. This includes treatment practices, in-market, and pipeline drugs, share of individual therapies, market performance across the seven major markets, market performance of key companies and their drugs, etc. The report also provides the current and future patient pool across the seven major markets. According to the report, the United States has the largest patient pool for Idiopathic Pulmonary Fibrosis and also represents the largest market for its treatment. Furthermore, the current treatment practice/algorithm, market drivers, challenges, opportunities, reimbursement scenario, unmet medical needs, etc., have also been provided in the report. This report is a must-read for manufacturers, investors, business strategists, researchers, consultants, and all those who have any kind of stake or are planning to foray into the Idiopathic Pulmonary Fibrosis market in any manner.

Time Period of the Study

Base Year: 2024
Historical Period: 2019-2024
Market Forecast: 2025-2035

Countries Covered

United States
Germany
France
United Kingdom
Italy
Spain
Japan

Analysis Covered Across Each Country

Historical, current, and future epidemiology scenario
Historical, current, and future performance of the Idiopathic Pulmonary Fibrosis market
Historical, current, and future performance of various therapeutic categories in the market
Sales of various drugs across the Idiopathic Pulmonary Fibrosis market
Reimbursement scenario in the market
In-market and pipeline drugs

Competitive Landscape:

This report also provides a detailed analysis of the current Idiopathic Pulmonary Fibrosis marketed drugs and late-stage pipeline drugs.

In-Market Drugs

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Drug Uptake and Market Performance

Late-Stage Pipeline Drugs

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Drug Uptake and Market Performance

Key Questions Answered in this Report:

Market Insights

How has the Idiopathic Pulmonary Fibrosis market performed so far and how will it perform in the coming years?
What are the markets shares of various therapeutic segments in 2024 and how are they expected to perform till 2035?
What was the country-wise size of the Idiopathic Pulmonary Fibrosis across the seven major markets in 2024 and what will it look like in 2035?
What is the growth rate of the Idiopathic Pulmonary Fibrosis across the seven major markets and what will be the expected growth over the next ten years?
What are the key unmet needs in the market?

Epidemiology Insights

What is the number of prevalent cases (2019-2035) of Idiopathic Pulmonary Fibrosis across the seven major markets?
What is the number of prevalent cases (2019-2035) of Idiopathic Pulmonary Fibrosis by age across the seven major markets?
What is the number of prevalent cases (2019-2035) of Idiopathic Pulmonary Fibrosis by gender across the seven major markets?
How many patients are diagnosed (2019-2035) with Idiopathic Pulmonary Fibrosis across the seven major markets?
What is the size of the Idiopathic Pulmonary Fibrosis patient pool (2019-2024) across the seven major markets?
What would be the forecasted patient pool (2025-2035) across the seven major markets?
What are the key factors driving the epidemiological trend Idiopathic Pulmonary Fibrosis of?
What will be the growth rate of patients across the seven major markets?

Current Treatment Scenario, Marketed Drugs, and Emerging Therapies

What are the current marketed drugs and what are their market performance?
What are the key pipeline drugs and how are they expected to perform in the coming years?
How safe are the current marketed drugs and what are their efficacies?
How safe are the late-stage pipeline drugs and what are their efficacies?
What are the current treatment guidelines for Idiopathic Pulmonary Fibrosis drugs across the seven major markets?
Who are the key companies in the market and what are their market shares?
What are the key mergers and acquisitions, licensing activities, collaborations, etc. related to the Idiopathic Pulmonary Fibrosis market?
What are the key regulatory events related to the Idiopathic Pulmonary Fibrosis market?
What is the structure of clinical trial landscape by status related to the Idiopathic Pulmonary Fibrosis market?
What is the structure of clinical trial landscape by phase related to the Idiopathic Pulmonary Fibrosis market?
What is the structure of clinical trial landscape by route of administration related to the Idiopathic Pulmonary Fibrosis market?

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Purchase Options Discount
Offer

Inquire Before Buying

Speak to an Analyst

Request Brochure

Request Customization

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-201-971-6302

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.